Access to Over the Counter (OTC) Drug Utilization Data
Contact and place of performance
Benjamin Golway
Silver Spring, MD 20993
USA
05/28/2020 - Amendment2 to FDA-RFP-1228764"Access to Over-the-Counter (OTC) Drug Utilization Data/Services" is posted to revise evaluation Factor 3. Pleaserefer to the attached RFP (Amendment 2). RFP revisions are highlighted in yellow in Amendment 2.
The Food and Drug Administration (FDA) Office of Acquisition and Grant Services is seeking access to Over-the-Counter (OTC) drug utilization data and related services. This requirement is classified under NAICS 541519 for Other Computer Related Services and PSC DA10 for IT and Telecom - Business Application/Application Development Software as a Service. The initiative aims to provide the agency with comprehensive data insights into the utilization of non-prescription medications, with the primary place of performance located in Silver Spring, Maryland.
The solicitation for this requirement, identified as FDA-RFP-1228764, is a combined synopsis and solicitation. Responses are due by June 8, 2020, following an initial publication on May 7, 2020. The procurement process has included several updates, including an amendment to revise evaluation Factor 3 as detailed in the five supporting documents, which consist of three PDF amendments and two versions of the Request for Proposal. Benjamin Golway serves as the point of contact for this federal opportunity.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.